TITLE

COMMENTARY: Enoxaparin for 7 days was better than unfractionated heparin for 2 days for reducing death and MI but not bleeding in STEMI

AUTHOR(S)
Massel, David
PUB. DATE
September 2006
SOURCE
ACP Journal Club;Sep/Oct2006, Vol. 145 Issue 2, p30
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents comments on the clinical study related to the usage of the drug enoxaparin for reducing death in patients with ST-elevation myocardial infarction. Enoxaparin use should be avoided in older people and patients with renal failure. In the study enoxaparin was involved in the prevention of nonfatal Ml at the cost of increased major bleeding. It was also found that enoxaparin was the favored drug.
ACCESSION #
22493467

 

Related Articles

  • Fondaparinux reduced death or reinfarction in acute ST-segment elevation myocardial infarction.  // ACP Journal Club;Sep/Oct2006, Vol. 145 Issue 2, p29 

    The article presents information on the method adopted to treat patients with acute ST-segment elevation myocardial infarction. The objective was to find out the effect of the drug fondaparinux in reducing reinfarction or death in patients. Randomized placebo-controlled trial was carried out on...

  • Fast, aggressive treatment for myocardial infarction urged. Mitka, Mike; Mitka, M // JAMA: Journal of the American Medical Association;12/20/2000, Vol. 284 Issue 23, p2985 

    Presents results from trials regarding myocardial infarction announced at the American Heart Association's annual scientific sessions in November 2000. Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) trial and the use of atorvastatin in treatment; Treat Angina with...

  • Reteplase.  // Reactions Weekly;10/13/2007, Issue 1173, p23 

    The article describes the case of a patient who developed retro-orbital hemorrhage during treatment with reteplase for an acute myocardial infarction. The patient presented with an acute ST-segment myocardial infarction and received reteplase. The symptoms associated with retro-orbital...

  • Giving aspirin and ibuprofen after myocardial infarction. Kimmel, Stephen E.; Strom, Brian L. // BMJ: British Medical Journal (International Edition);12/6/2003, Vol. 327 Issue 7427, p1298 

    Comments on research in the use of aspirin and ibuprofen after myocardial infarction. Mention of the challanges in designing a pharmacodynamic study questioning whether ibuprofen can inhibit aspirin's antiplatelet effect; Three studies that measure the clinical effects of combining ibuprofen and...

  • Effects of statin treatment in patients with coronary artery disease and chronic kidney disease. Kaneko, Hidehiro; Yajima, Junji; Oikawa, Yuji; Tanaka, Shingo; Fukamachi, Daisuke; Suzuki, Shinya; Sagara, Koichi; Otsuka, Takayuki; Matsuno, Shunsuke; Funada, Ryuichi; Kano, Hiroto; Uejima, Tokuhisa; Koike, Akira; Nagashima, Kazuyuki; Kirigaya, Hajime; Sawada, Hitoshi; Aizawa, Tadanori; Yamashita, Takeshi // Heart & Vessels;Jan2014, Vol. 29 Issue 1, p21 

    Statins reduce cardiovascular morbidity and mortality from coronary artery disease (CAD). However, the effects of statin therapy in patients with CAD and chronic kidney disease (CKD) remain unclear. Within a single hospital-based cohort in the Shinken Database 2004-2010 comprising all patients (...

  • Drug-Eluting Stents in Patients with Chronic Kidney Disease: A Prospective Registry Study. Shenoy, Chetan; Boura, Judy; Orshaw, Pamela; Harjai, Kishore J. // PLoS ONE;2010, Vol. 5 Issue 11, p1 

    Background: Chronic kidney disease (CKD) is strongly associated with adverse outcomes after percutaneous coronary intervention (PCI). There are limited data on the effectiveness of drug-eluting stents (DES) in patients with CKD. Methodology/Principal Findings: Of 3,752 consecutive patients...

  • D. Dialysis.  // Kidney;Mar/Apr2008, Vol. 17 Issue 2, p92 

    The article presents a literature survey on the conduct of dialysis in nephropathy. It states that dialysis patients that are hospitalized after acute myocardial infarction (AMI) differ greatly from nondialysis patients and that accurate recognition of AMI among these patients is needed. In...

  • Review: Routine invasive management after unstable angina or non--ST-segment elevation MI reduces risk for death or MI.  // ACP Journal Club;Nov/Dec2005, Vol. 143 Issue 3, p69 

    This article presents information on a clinical study according to which routine invasive management after unstable angina or non-ST-segment elevation myocardial infarction (NSTEMI) reduces risk for death or MI. The study explored whether in patients with unstable angina or NSTEMI, initial...

  • Aspirin for all over 50 revisited. Elwood, Peter; Morgan, Gareth // Heart;Nov2008, Vol. 94 Issue 11, p1364 

    The article reports on a study of the risks of aspirin prophylaxis among diabetic patients with ages ranging between 30 to 74 years. It states that vascular risk of aspirin prophylaxis is estimated to people whose age is 48 years old for men and 57 years old for women. It also mentions that...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics